Related Experiment Video
Updated: Jun 20, 2025
10:48
Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression
Published on: May 15, 2014
11.4K
Picroside II disrupts IBDV replication via targeting VP1 polymerase
Donghu Zhang1, Jing Wang2, Huansheng Wu3
1School of Pharmacy, China Medical University, Shenyang, Liaoning 110122, PR China; Department of Pharmacy, the First Hospital of China Medical University, Shenyang, Liaoning 110001, P R China.
Veterinary Microbiology
|July 20, 2024
Summary
Picroside II effectively inhibits Infectious Bursal Disease Virus (IBDV) replication by targeting viral polymerase. This natural compound shows lasting antiviral effects, offering a promising therapeutic option for IBDV infections in poultry.
Area of Science:
- Virology
- Poultry Health
- Natural Product Chemistry
Background:
- Infectious Bursal Disease Virus (IBDV) causes significant economic losses in poultry due to high mortality and vaccine-evading strains.
- The poultry industry urgently needs novel antiviral therapies for IBDV due to the limitations of current vaccines.
- Existing treatments for IBDV are limited, highlighting the need for new therapeutic strategies.
Purpose of the Study:
- To evaluate the antiviral efficacy of picroside II, a natural iridoid glycoside, against IBDV.
- To elucidate the mechanism of action of picroside II in inhibiting IBDV replication.
- To assess the therapeutic potential of picroside II as an antiviral agent for IBDV.
Main Methods:
- In vitro antiviral assays using DF-1 cells infected with IBDV.
- Time-addition and antiviral duration analyses to determine the stage of viral replication targeted.
- Biochemical assays to investigate the interaction of picroside II with IBDV VP1 polymerase and VP3.
- Site-directed mutagenesis of VP1 to identify critical binding sites.
Main Results:
- Picroside II demonstrated significant dose-dependent inhibition of IBDV replication in DF-1 cells.
- Antiviral effects of picroside II persisted for over 72 hours, indicating sustained therapeutic action.
- Picroside II was found to inhibit the cellular replication stage of the IBDV lifecycle.
- The compound impairs IBDV VP1 polymerase activity by binding to its active pocket, disrupting VP1-VP3 interactions.
- Mutations in critical VP1 binding sites abolished polymerase function and viral replication.
Conclusions:
- Picroside II exhibits potent antiviral activity against IBDV by inhibiting viral polymerase activity.
- The natural compound disrupts essential viral replication steps, including polymerase function and protein interactions.
- Picroside II represents a promising lead compound for the development of novel antiviral therapies against IBDV in poultry.
Related Concept Videos
02:57piRNA - Piwi-interacting RNAs
6.8K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.8K
02:28Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
02:33Retroviruses
12.2K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.2K
01:52Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K